Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
TD139
|
| gptkbp:ATCCode |
none
|
| gptkbp:chemicalClass |
small molecule
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Galecto_Biotech
|
| https://www.w3.org/2000/01/rdf-schema#label |
GB0139
|
| gptkbp:intendedUse |
treatment of idiopathic pulmonary fibrosis
|
| gptkbp:mechanismOfAction |
galectin-3 inhibitor
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:status |
investigational
|
| gptkbp:target |
galectin-3
|
| gptkbp:bfsParent |
gptkb:Galecto_Biotech
|
| gptkbp:bfsLayer |
8
|